financetom
Business
financetom
/
Business
/
Nuvei Introduces New Features for its Nuvei for Platforms Product
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nuvei Introduces New Features for its Nuvei for Platforms Product
Oct 3, 2024 12:57 AM

09:38 AM EDT, 09/24/2024 (MT Newswires) -- Nuvei ( NVEI ) said Tuesday that it introduced several new features and enhancements for its Nuvei ( NVEI ) for Platforms product, including seller invoicing, automatic reconciliation and splitting payments to separate commissions and sellers' fees.

"By enhancing the embedded payments capabilities of our platform, we're enabling our customers - from marketplaces and commerce platforms to payment facilitators and software providers - to offer a seamless, customized payments experience that unlocks new growth opportunities," said Nuvei Chair and CEO Philip Fayer.

Price: 44.94, Change: -0.10, Percent Change: -0.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Online university American Public Education's Q3 revenue beats estimates
Online university American Public Education's Q3 revenue beats estimates
Nov 10, 2025
Overview * American Public Education ( APEI ) Q3 revenue grows 7% yr/yr, beating analyst expectations * Net income for Q3 rises 660% yr/yr to $5.6 mln * Adjusted EBITDA for Q3 increases 60% to $20.7 mln Outlook * Company expects Q4 2025 revenue between $150 mln and $153.5 mln, down 6% to 9% * Company sees full-year 2025 revenue...
Orchestra BioMed Q3 revenue beats expectations
Orchestra BioMed Q3 revenue beats expectations
Nov 10, 2025
Overview * Orchestra BioMed ( OBIO ) Q3 revenue beats analyst expectations at $0.9 mln * Company secured $147.6 mln in proceeds from strategic transactions and equity offerings * Expanded collaborations with Medtronic and Terumo, enhancing strategic partnerships Outlook * Company expects to complete Virtue Trial enrollment by mid-2027 * Orchestra BioMed extends cash runway into Q4 2027 * Company...
Tulip grower Lendway's Q3 net revenue falls
Tulip grower Lendway's Q3 net revenue falls
Nov 10, 2025
Overview * Lendway Q3 2025 net revenue falls to $5.2 mln from $6.6 mln in Q3 2024 * Company's Q3 2025 operating loss widens to $3.0 mln from $1.4 mln in Q3 2024 * Net loss attributable to Lendway increases to $2.9 mln from $1.1 mln in Q3 2024 Outlook * Lendway ( LDWY ) expects revenue to increase in...
Terns Pharmaceuticals posts narrower than expected Q3 net loss
Terns Pharmaceuticals posts narrower than expected Q3 net loss
Nov 10, 2025
Overview * Terns reports Q3 net loss of $24.6 mln, less than analysts' expectations * Company highlights promising Phase 1 CARDINAL trial results for TERN-701 in CML * Terns shifts focus to oncology, seeks partners for metabolic programs Outlook * Company expects cash reserves to support operations into 2028 * Terns to present expanded CARDINAL trial data at ASH meeting...
Copyright 2023-2026 - www.financetom.com All Rights Reserved